Patterns of Recurrence Following Complete Response to Regional Chemotherapy for In-Transit Melanoma

@article{MPHKetanSharma2012PatternsOR,
  title={Patterns of Recurrence Following Complete Response to Regional Chemotherapy for In-Transit Melanoma},
  author={BA MPHKetanSharma and Georgia M. Beasley and R. Steven Turley and Amanda K. Raymond and MS GloriaBroadwater and Bercedis Peterson and PhD Paul Mosca and Douglas M Tyler},
  journal={Annals of Surgical Oncology},
  year={2012},
  volume={19},
  pages={2563-2571}
}
Even after complete response (CR) to regional chemotherapy for in-transit melanoma, many patients develop recurrence. Understanding the probability, location, and timing of recurrences can optimize management strategies for this patient population. A prospective database identified patients who underwent 81 first-time hyperthermic isolated limb perfusions (HILPs) and 133 first-time isolated limb infusions (ILIs). Response was defined using the response evaluation criteria in solid tumors… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 11 extracted citations

Regional therapies for in-transit disease.

Surgical oncology clinics of North America • 2015
View 5 Excerpts
Highly Influenced

Melanoma, Version 2.2016, NCCN Clinical Practice Guidelines in Oncology.

Journal of the National Comprehensive Cancer Network : JNCCN • 2016

References

Publications referenced by this paper.
Showing 1-10 of 32 references

Final results of a prospective multi-center phase II trial of systemic ADH-1 in combination with melphalan via isolated limb infusion (M-ILI) in patients with advanced extremity melanoma

GM Beasley, G Sanders, N McMahon
Ann Surg Oncol • 2010

Final version of 2009 AJCC melanoma staging and classification.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology • 2009
View 2 Excerpts

Similar Papers

Loading similar papers…